O
Occuity
Optical Healthcare Monitoring And Screening | Occuity | Reading
About Occuity
Occuity is a health technology startup that specializes in the development of medical devices for the screening and monitoring of chronic diseases such as diabetes, Alzheimer's, glaucoma, and myopia. The company's unique approach involves using the eye as a 'window to the health of the body', a concept they refer to as 'Oculomics'.
Read full description
Occuity's innovative technology is protected by 9 international patents, covering the measurement technique and optical technology that forms the basis of their devices. Additional patents relate to the alignment and measurements within the eye. This intellectual property forms the backbone of their business model, allowing them to create unique, cutting-edge products.
The company's primary market includes high street pharmacies and care homes, where their devices can be used for non-clinical disease screening. This makes the process of detecting chronic diseases easier, cheaper, and safer, potentially revolutionizing the way these conditions are managed.
Occuity's business model is likely based on the sale of their patented devices to these establishments, as well as the potential for ongoing service or maintenance contracts. The company's work presents an exciting opportunity for a significant shift in optometry practice and chronic disease management over the next decade.
At a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Reading, United Kingdom
- Employees
- 44
- Open positions
- 2
- Dealroom signal
- 80.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Diabetes, Ophthalmology, Remote Monitoring, Alzheimers Disease, Screening, Health Diagnostics, Metabolism, Physician Support Tools
- Technology
- Hardware
- Business model
- Manufacturing
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Jul 2026 | $2M | — | UK Research and Innovation | ↗ |
| EARLY VC✓Equity / VC | Dec 2025 | $1.5M | $53M | Republic Europe | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Occuity is 7K monthly website visits, up 84.2% over the last three months. Occuity's team grew 7.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Business Angels
Angel Investment Network
Republic Europe
UK Research and Innovation
Series A1 investor entered at this stage
Remidio
Other known investors1 additional known investor
LongevityTech.fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Occuity on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Occuity’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.